Is your content review process fast enough? has been saved
Services
Is your content review process fast enough?
Automated content review services for life sciences
The marketing of life sciences (LS) products comes with labor-intensive and costly medical, legal, and regulatory obligations—and AI-driven content review can help address them. Learn how our Digital Content Review Services powered by IntelliDoc™ can help LS companies reduce content review timelines and cost, empower personalization, and improve customer engagement, compliantly.
Diagnosing the challenges in LS product marketing
Modern approaches, such as consumer personalization and omnichannel engagement, require high volumes of marketing materials and rapid distribution. However, many enterprises lack the necessary process, technology, and talent, resulting in disjointed and slow processing times.
As the attention shifts toward AI-driven approaches, many organizations have yet to secure the foundational elements needed for execution—including digital asset management (DAM), consistent content tagging processes, and taxonomy alignment. These roadblocks are further intensified as regulations increasingly affect how products are advertised to the public. By streamlining content review workflows, LS organizations can drive positive patient outcomes and address compliance requirements along the way.
From risk to remedy
Regulatory and reputational risk can arise as manual processes are leveraged to address the LS industry’s extensive marketing content review requirements. As these risk factors grow and create intersecting challenges for marketers, AI-enabled content review is key to driving marketing value.
Our Digital Content Review Services powered by IntelliDoc™ enable risk mitigation for marketing materials within the LS industry. Our professionals leverage IntelliDoc, our technology solution fueled by machine learning and AI, to help scale automation throughout your content review cycle.
We can program repeatable processes, such as including applicable disclaimers and proper brand-name usage, to help establish resilient controls throughout your content review—and with the use of AI and large language models (LLMs), the solution evolves in value over time. And as regulations evolve, our team can set new rulesets to meet the marketing requirements for pharmaceutical, medical device, and other biotechnology products. By pairing our knowledgeable talent with our automation-fueled technology, we can help remedy content review challenges for LS organizations.
Want to continue the conversation? Reach out to see how our team could help your LS enterprise optimize the content review journey with IntelliDoc.
Contacts
Bill Carter |
Mark Stevenson |
Jonathan Russell |
Sudeep Misra |
Recommendations
Life Sciences Compliance and Ethics Solutions
Learn how Deloitte can help you understand the regulatory landscape and evolving risks that are critical to your life sciences compliance efforts.
ConvergeHEALTH™ CognitiveSpark™ for Marketing
Boost customer engagement while protecting their data with CognitiveSpark™ for Marketing, our AI-driven, cloud-based solution.